These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16126036)

  • 21. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
    Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
    Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to prevent invasive candidal infection in extremely preterm infants.
    Kaufman DA; Manzoni P
    Clin Perinatol; 2010 Sep; 37(3):611-28. PubMed ID: 20813274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial.
    Kirpal H; Gathwala G; Chaudhary U; Sharma D
    J Matern Fetal Neonatal Med; 2016; 29(4):624-8. PubMed ID: 25708488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Candida surveillance cultures for identification of a preterm subpopulation at highest risk for invasive fungal infection.
    Vendettuoli V; Tana M; Tirone C; Posteraro B; La Sorda M; Fadda G; Romagnoli C; Vento G
    Pediatr Infect Dis J; 2008 Dec; 27(12):1114-6. PubMed ID: 18978516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungal Ecology in a Tertiary Neonatal Intensive Care Unit after 16 Years of Routine Fluconazole Prophylaxis: No Emergence of Native Fluconazole-Resistant Strains.
    Luparia M; Landi F; Mesini A; Militello MA; Galletto P; Farina D; Castagnola E; Manzoni P
    Am J Perinatol; 2019 Jul; 36(S 02):S126-S133. PubMed ID: 31238373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of invasive Candida infections in preterm infants: the time is now.
    Kaufman DA
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):393-9. PubMed ID: 18662105
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluconazole to prevent systemic fungal infections in infants: reviewing the evidence.
    Wilkerson J; McPherson C; Donze A
    Neonatal Netw; 2010; 29(5):323-33. PubMed ID: 20829180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.
    Kaufman DA
    Early Hum Dev; 2012 May; 88 Suppl 2():S45-9. PubMed ID: 22633513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety.
    Kaufman DA; Morris A; Gurka MJ; Kapik B; Hetherington S
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S87-90. PubMed ID: 24709470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal therapy for neonatal candidiasis.
    Zaoutis T; Walsh TJ
    Curr Opin Infect Dis; 2007 Dec; 20(6):592-7. PubMed ID: 17975409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
    Aghai ZH; Mudduluru M; Nakhla TA; Amendolia B; Longo D; Kemble N; Kaki S; Sutsko R; Saslow JG; Stahl GE
    J Perinatol; 2006 Sep; 26(9):550-5. PubMed ID: 16940972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for the prevention of neonatal candidiasis.
    Leibovitz E
    Pediatr Neonatol; 2012 Apr; 53(2):83-9. PubMed ID: 22503254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.
    Uko S; Soghier LM; Vega M; Marsh J; Reinersman GT; Herring L; Dave VA; Nafday S; Brion LP
    Pediatrics; 2006 Apr; 117(4):1243-52. PubMed ID: 16585321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted fluconazole prophylaxis for high-risk very low birth weight infants.
    Rolnitsky A; Levy I; Sirota L; Shalit I; Klinger G
    Eur J Pediatr; 2012 Oct; 171(10):1481-7. PubMed ID: 22628137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure.
    Weitkamp JH; Ozdas A; LaFleur B; Potts AL
    J Perinatol; 2008 Jun; 28(6):405-11. PubMed ID: 18185518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is routine fluconazole prophylaxis necessary in preterm infants?
    Morales-Molina JA; Mateu-de Antonio J; Grau S; Luque S; Berenguer N
    Pharm World Sci; 2006 Jun; 28(3):163-4. PubMed ID: 17004020
    [No Abstract]   [Full Text] [Related]  

  • 38. Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit.
    Saiman L
    Curr Opin Pediatr; 2006 Apr; 18(2):101-6. PubMed ID: 16601486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
    Fridkin SK; Kaufman D; Edwards JR; Shetty S; Horan T
    Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.